Swarthmore, PA, United States of America

Marcie A Glicksman

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 1995-1998

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Marcie A Glicksman: Innovator in Neurological Treatments

Introduction

Marcie A Glicksman is a prominent inventor based in Swarthmore, PA, known for her significant contributions to the field of neurological disorders. With a total of seven patents to her name, Glicksman has made remarkable strides in developing innovative treatments that target complex neurological conditions.

Latest Patents

Among her latest patents, Glicksman has developed protein kinase inhibitors for the treatment of neurological disorders. This invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. The invention also includes a method for treating diseased neuronal cells through the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.

Career Highlights

Throughout her career, Glicksman has worked with notable companies such as Cephalon, Inc. and Kyowa Hakko Kogyo Co., Ltd. Her work in these organizations has allowed her to advance her research and contribute to the development of effective treatments for neurological disorders.

Collaborations

Glicksman has collaborated with esteemed colleagues, including Nicola T Neff and Chikara Murakata. These partnerships have played a crucial role in her research and the successful development of her patented inventions.

Conclusion

Marcie A Glicksman is a trailblazer in the field of neurological treatments, with a strong portfolio of patents that reflect her dedication to innovation. Her work continues to impact the lives of those affected by neurological disorders, showcasing the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…